Skip to main content

Pfizer Inc (PFE) Stock

Pfizer Inc Stock Details, Movements and Public Alerts

Stock Details

Pfizer Inc (PFE), a prominent company in the healthcare sector within the drug manufacturers - general industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $24.30. Over the past 52 weeks, it has ranged between $20.18 and $27.69. This places the current price at 87.8% of its 52-week high and 20.4% above its 52-week low. Recent trading volume was recorded at 157,337,726. The 14-day Relative Strength Index (RSI) stands at 42.28, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $24.84 by 2.17%. Similarly, it is above its 200-day moving average of $24.21 by 0.37%. The MACD histogram is -0.07, indicating bearish momentum (MACD Line: -0.11, Signal Line: -0.04). The International Securities Identification Number (ISIN) for this stock is US7170811035. There are currently 4 active alerts set for PFE by users.

52-Week Range

$27.69 - $20.18

-12.24% from high · +20.42% from low

Avg Daily Volume

48,427,319

20-day average

100-day avg: 46,089,204

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

12.55

Below market average

Forward P/E

7.61

Earnings expected to grow

PEG Ratio

0.95

Potentially undervalued

Price to Book

1.52

EV/EBITDA

9.07

EPS (TTM)

$1.90

Price to Sales

2.12

Beta

0.46

Less volatile than market

How is PFE valued relative to its earnings and growth?
Pfizer Inc trades at a P/E ratio of 12.55, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 7.61 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 0.95 suggests the stock may be undervalued relative to its growth rate.
What is PFE's risk profile compared to the market?
With a beta of 0.46, Pfizer Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.52 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

16.80%

Operating Margin

28.70%

EBITDA

$24.51B

Return on Equity

12.20%

Return on Assets

5.25%

Revenue Growth (YoY)

10.30%

Earnings Growth (YoY)

6974.00%

How profitable and efficient is PFE's business model?
Pfizer Inc achieves a profit margin of 16.80%, meaning it retains $16.80 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 28.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 12.20% and ROA at 5.25%, the company achieves moderate returns on invested capital.
What are PFE's recent growth trends?
Pfizer Inc's revenue grew by 10.30% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 6974.00% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against DRUG MANUFACTURERS - GENERAL industry averages for proper context.

Dividend Information

Dividend Per Share

$1.70

Dividend Yield

7.15%

Ex-Dividend Date

Jul 25, 2025

Dividend Date

Sep 2, 2025

What dividend income can investors expect from PFE?
Pfizer Inc offers a dividend yield of 7.15%, paying $1.70 per share annually. This high yield exceeds 4%, significantly outperforming the S&P 500 average of 1.5-2% and most investment-grade bonds. For income-focused investors, this represents an attractive cash flow opportunity, though high yields sometimes signal market concerns about sustainability. To receive the next dividend, shares must be purchased before the ex-dividend date of Jul 25, 2025.
How reliable is PFE's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Pfizer Inc pays $1.70 per share in dividends against earnings of $1.90 per share, resulting in a payout ratio of 89.47%. This high payout ratio of 60-90% leaves limited earnings for reinvestment. While currently sustainable, there's less buffer for dividend growth or protection during earnings downturns. The next dividend payment is scheduled for Sep 2, 2025.

Company Size & Market

Market Cap

$135.6B

Revenue (TTM)

$63.83B

Revenue/Share (TTM)

$11.25

Shares Outstanding

5.69B

Book Value/Share

$15.60

Asset Type

Common Stock

What is PFE's market capitalization and position?
Pfizer Inc has a market capitalization of $135.6B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 5.69B shares outstanding, the company's ownership is widely distributed. As a major player in the DRUG MANUFACTURERS - GENERAL industry, it competes with other firms in this sector.
How does PFE's price compare to its book value?
Pfizer Inc's book value per share is $15.60, while the current stock price is $24.30, resulting in a price-to-book (P/B) ratio of 1.56. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$28.90

18.93% upside potential

Analyst Recommendations

Strong Buy

1

Buy

7

Hold

15

Sell

1

Strong Sell

0

How reliable are analyst predictions for PFE?
24 analysts cover PFE with 33% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $28.90 implies 18.9% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PFE?
Current analyst recommendations:1 Strong Buy, 7 Buy, 15 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 1, 2025, 07:29 AM

Technical Indicators

RSI (14-day)

42.28

Neutral

50-Day Moving Average

$24.84

-2.17% below MA-50

200-Day Moving Average

$24.21

0.37% above MA-200

MACD Line

-0.11

MACD Signal

-0.04

MACD Histogram

-0.07

Bearish

What does PFE's RSI value tell investors?
The RSI (Relative Strength Index) for PFE is currently 42.28, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret PFE's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.11 below the signal line at -0.04, with histogram at -0.07. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($24.84) is above the 200-day MA ($24.21), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Oct 30, 2025, 12:46 AM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Oct 30, 2025, 04:29 PM
Alert Condition
RSI Threshold Cross
Threshold
40
Created
Oct 29, 2025, 04:30 PM
Alert Condition
Forward P/E falls below
Threshold
7.5 x
Created
Oct 28, 2025, 04:36 PM
Alert Condition
Price rises above
Threshold
$29.00
Created
Sep 6, 2025, 08:46 AM

Stay Ahead of the Market with Pfizer Inc Alerts

Set up price alerts for Pfizer Inc and get notified instantly when the price hits your target. Never miss an important price movement again.